A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis

NCT05999799 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
161
Enrollment
INDUSTRY
Sponsor class

Stopped Sponsor decision to early terminate the study based on the pre-defined futility criterion for efficacy. No safety concerns were identified.

Conditions

Interventions

Sponsor

GlaxoSmithKline